Audited Supplier
750mg
Surgery
Intramuscular Administration
Adult
Solid
Powder
Biological Products
Chemical Synthesis
Reduce The Development of Drug-Resistant Bacteria
Color From Light Yellow to Amber
No
as Per Customerized
500mg/1g
China
3004909099
Product Description
Rx Only
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefuroxime for Injection and other antibacterial drugs, Cefuroxime for Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
The drug is a kind of white or light yellow powder or crystallized powder.The drug is indicated for the treatment of the respiratory tract and otorhinolaryngological infection and so on.
for I.V or I.M
Indications
| Respiratory tract infections | acute and chronic bronchitis, infectious bronchitis, bacterial pneumonia, pulmonary abscess, and postoperative chest infections |
| ears, nose, and throat infection | sinusitis, tonsillitis, pharyngitis |
| urinary tract infections | acute, chronic pyelonephritis, cystitis and asymptomatic bacteriuria. |
| skin and soft tissue infections | cellulitis, erysipelas, peritonitis and wound infection. |
| bone and joint infections | osteomyelitis and septic arthritis |
| obstetrics and gynecological infections | pelvic inflammatory disease |
| gonorrhea | especially suitable for use in the treatment of penicillin |
| other infections | including sepsis and meningitis; abdominal pelvic and orthopedic surgery; Heart, lung, esophagus and vascular surgery; total joint replacement surgery to prevent infection. |
Cefuroxime for Injection, USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:
- Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, and Escherichia coli.
- Urinary Tract Infections caused by Escherichia coli and Klebsiella spp.
- Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp., and Enterobacter spp.
- Septicemia caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.
- Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis, and Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).
- Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and females.
- Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).
(1) 1 bottles / box (0.75g); (2) 10 bottles / box; (3) 6 bottles / box (2.0g, 2.25g, 2.5G, 3.0g).
Storage
Keep in dark place and tight package, Store in cool ( under a temperatyre of 20° C )
